Pharmacophore-based screening of differentially-expressed PGF, DDIT4, COMP and CHI3L1 from hMSC cell lines reveals five novel therapeutic compounds for primary osteoporosis
As many societies age, primary osteoporosis (PO) is increasingly a major health problem. Current drug treatments such as alendronate and risedronate have known side effects. We took an agnostic empirical approach to find PO therapeutic compounds. We examined 13,548,960 probe data-points from mesench...
Main Author: | Catherine Jessica Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2016-06-01
|
Series: | Journal of Genetic Engineering and Biotechnology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1687157X15000633 |
Similar Items
-
Three Dimensional Pharmacophore Modelling of Monoamine oxidase-A (MAO-A) inhibitors
by: Swatantra K. Jain, et al.
Published: (2007-09-01) -
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
by: Yinglan Pu, et al.
Published: (2017-06-01) -
Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures
by: Alina Kutlushina, et al.
Published: (2018-11-01) -
Combined Pharmacophore Modeling, Docking, and 3D-QSAR Studies of PLK1 Inhibitors
by: Tao Lu, et al.
Published: (2011-12-01) -
Structure-Based Virtual Screening of <i>Pseudomonas aeruginosa</i> LpxA Inhibitors using Pharmacophore-Based Approach
by: Baki Vijaya Bhaskar, et al.
Published: (2020-02-01)